Skip to main content

Lung Cancer

Lung Cancer, Oncology

My Practice: Roles and Responsibilities

Edward Garon, MD

Lung Cancer, Oncology

Challenges in Managing Toxicities

Edward Garon, MD

Lung Cancer, Oncology

Nivolumab plus Ipilimumab Combination Promotes Durable Responses in Advanced Lung Cancer

Lung Cancer, Oncology

Alectinib Potential First-Line Treatment for NSCLC Associated with ALK Mutation

In the News, Lung Cancer, Oncology

New Data Show Osimertinib Effective as First-Line Treatment of NSCLC with EGFR Mutation

Lilly Ostrovsky

Lilly Ostrovsky

Lung Cancer, Oncology

Necitumumab Extends Survival of Patients with Squamous Lung Cancer

Lung Cancer, Oncology

Ramucirumab Shows Survival Benefit in NSCLC

Caroline Helwick

Lung Cancer, Oncology

Crizotinib Superior to Standard Chemotherapy in ALK-Positive Lung Cancer

Lung Cancer, Oncology

Current Treatment of Advanced NSCLC Requires Testing for Driver Mutations

Lung Cancer, Oncology

Afatinib Doubles Progression-Free Survival Compared with Chemotherapy in Patients with Lung Cancer

Page 4 of 5
Results 31 - 40 of 44